Objectives: Aim of this study is to report and discuss the results of 4 years of Newborn hearing screening (NHS)program at the Neonatal Intensive Care Unit (NICU), particularly evaluating the clinical ABR results. Methods: Retrospective study. NHS data from NICU newborns, admitted for ≥5 days, in the period from January 1st, 2013 and December 31st, 2016, were retrieved and analyzed. NHS results were classified as following: (i)“pass” when both ears for both the a-TEOAE (automated Transient-Evoked Otoacoustic Emissions)and the a-ABR (automated Auditory Brainstem Response)protocol resulted as “pass”; (ii)“fail” when one ear, at either one of the two performed tests resulted as “fail”; (iii)“missing” when the newborns were not tested with both protocols. All “fail” and “missing” newborns were retested (with both tests): in the case of a second “fail” result, a clinical ABR was performed within a period of 3 months. Results: A total of 1191 newborns were screened. From those, 1044/1191 resulted as “pass”, 108/1191 as “fail”, and 39/1191 as “missing”. During the re-testing of these 147 newborns, 43 were assigned as “missing”, 63 were assigned as “pass” (showing bilaterally a wave V identifiable within 30 dB nHL)and 25 failed the retest and/or did not present an identifiable wave V within 30 dB nHL. Among the 147 retested infants, we identified a group of 16 subjects who resulted as NHS “refer” and who, during the audiological follow-up, showed either: (i)a unilateral or bilateral wave V identifiable over 30 dB nHL, at the first clinical ABR assessment; or (ii)a bilateral wave V identifiable within 30 dB nHL, in a following clinical ABR test during the first year of life. These 16 subjects were defined to have an ‘Auditory Brainstem Maturation’ issue. Conclusions: A possible “maturation” of the ABR response (and therefore of the auditory pathway)has been hypothesised in 16 out of 1191 infants (1.3%). A delay of the auditory pathway maturation in preterm babies compared to term newborns has already been suggested in the literature. A possible delay of the NHS retest could be considered, in selected cases, with significant savings in economic resources and parental anxiety.
Newborn hearing screening at the Neonatal Intensive Care Unit and Auditory Brainstem Maturation in preterm infants
Ciorba A
Primo
;Hatzopoulos SSecondo
;Corazzi V;Cogliandolo C;Aimoni C;Bianchini C;Stomeo FPenultimo
;Pelucchi S.Ultimo
2019
Abstract
Objectives: Aim of this study is to report and discuss the results of 4 years of Newborn hearing screening (NHS)program at the Neonatal Intensive Care Unit (NICU), particularly evaluating the clinical ABR results. Methods: Retrospective study. NHS data from NICU newborns, admitted for ≥5 days, in the period from January 1st, 2013 and December 31st, 2016, were retrieved and analyzed. NHS results were classified as following: (i)“pass” when both ears for both the a-TEOAE (automated Transient-Evoked Otoacoustic Emissions)and the a-ABR (automated Auditory Brainstem Response)protocol resulted as “pass”; (ii)“fail” when one ear, at either one of the two performed tests resulted as “fail”; (iii)“missing” when the newborns were not tested with both protocols. All “fail” and “missing” newborns were retested (with both tests): in the case of a second “fail” result, a clinical ABR was performed within a period of 3 months. Results: A total of 1191 newborns were screened. From those, 1044/1191 resulted as “pass”, 108/1191 as “fail”, and 39/1191 as “missing”. During the re-testing of these 147 newborns, 43 were assigned as “missing”, 63 were assigned as “pass” (showing bilaterally a wave V identifiable within 30 dB nHL)and 25 failed the retest and/or did not present an identifiable wave V within 30 dB nHL. Among the 147 retested infants, we identified a group of 16 subjects who resulted as NHS “refer” and who, during the audiological follow-up, showed either: (i)a unilateral or bilateral wave V identifiable over 30 dB nHL, at the first clinical ABR assessment; or (ii)a bilateral wave V identifiable within 30 dB nHL, in a following clinical ABR test during the first year of life. These 16 subjects were defined to have an ‘Auditory Brainstem Maturation’ issue. Conclusions: A possible “maturation” of the ABR response (and therefore of the auditory pathway)has been hypothesised in 16 out of 1191 infants (1.3%). A delay of the auditory pathway maturation in preterm babies compared to term newborns has already been suggested in the literature. A possible delay of the NHS retest could be considered, in selected cases, with significant savings in economic resources and parental anxiety.File | Dimensione | Formato | |
---|---|---|---|
IJPOto 2019.pdf
solo gestori archivio
Descrizione: versione editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
670.84 kB
Formato
Adobe PDF
|
670.84 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.